Boundless Bio, Inc. (BOLD) vs Gossamer Bio, Inc. (GOSS)
A side-by-side comparison of Boundless Bio, Inc. and Gossamer Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLD
Boundless Bio, Inc.
$2.61HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
GOSS
Gossamer Bio, Inc.
$10.61HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT
Total return — BOLD vs GOSS
growth of $100 · dividends reinvested · last 3yBOLD -81.8% (-43.3%/yr)GOSS -88.7% (-51.7%/yr)BOLD compounded faster over this window
BOLD GOSS
BOLD vs GOSS: by the numbers
- •GOSS is the larger company ($65M vs $59M market cap).
- •Both run net losses; BOLD's is the smaller (0.00% vs -235.00% net margin).
Metrics side by side
Valuation
| Metric | BOLD | GOSS |
|---|---|---|
| P/S ratio | N/A | 1.22 |
| P/B ratio | 0.89 | N/A |
Profitability
| Metric | BOLD | GOSS |
|---|---|---|
| Gross margin | 0.00% | 99.56% |
| Operating margin | 0.00% | -336.81% |
| Net margin | 0.00% | -235.00% |
| ROE | -58.99% | N/A |
| ROIC | -43.97% | N/A |
Growth (annualized)
| Metric | BOLD | GOSS |
|---|---|---|
| Total return CAGR (5Y) | N/A | -59.51% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.